TrialJournal of clinical pharmacology2016

Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia.

Xiaoping Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.